Except if it’s the state’s medical marijuana industry.
Of the 146 banks and credit unions operating in the state, a mere five three banks and two credit unions are banking licensed marijuana operators, and to a limited extent, mainly focused on deposit services and cash management rather than loans, according to an industry expert.
Strict and costly compliance measures to ensure institutions don’t run afoul of federal law, which still deems marijuana to be illegal, are a key worry. Also playing a role is a conservative culture within many banks and concerns about offending certain clients, despite a growing public acceptance of the drug.
CT Folk highlights homegrown musicians in virtual concert middletownpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from middletownpress.com Daily Mail and Mail on Sunday newspapers.
By Natalie Missakian
Just 10 months after Rallybio launched in early 2018, Fierce Biotech, an international trade journal widely followed in the bioscience world, dubbed it one of the year’s 15 most promising biotechs.
The New Haven-based company had yet to make any groundbreaking discoveries. In fact, it didn’t have a single drug in its portfolio. And outside of its announced focus on treatments for severe rare diseases, Rallybio’s founders had offered few details about what medical conditions the startup planned to pursue.
Still, the company was getting noticed not only by reporters covering the industry but also by investors as evidenced by the $37 million it raised shortly after setting up its first lab and office at UConn’s Technology Incubation Program (TIP) in Farmington.
CT Folk highlights homegrown musicians in virtual concert wiltonbulletin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wiltonbulletin.com Daily Mail and Mail on Sunday newspapers.